Mucinous tubular and spindle cell carcinoma of the kidney: the contrast-enhanced ultrasonography and CT features of six cases and review of the literature.

Qing Zhang, Wei Wang, Shiwei Zhang, Xiaozhi Zhao, Shun Zhang, Guangxiang Liu, Hongqian Guo

Journal: International urology and nephrology 2015;46(12):2311-7

PMID: 25158894

Abstract

PURPOSE

To report the features of contrast-enhanced ultrasonography (CEUS) and computer tomography (CECT) of mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney.

METHODS

Six cases of MTSCC of the kidney were studied, and the literature was reviewed. Ultrasonography, CEUS, and CECT examinations were routinely performed before the operation. Histological analysis, including HE staining and immunohistochemistry, was performed with the envision method.

RESULTS

The age of the patients ranged from 48 to 75 years (mean 55.5 years). One patient was male, and five were females. All six tumours exhibited an admixture of tubules, spindle cells, and mucinous stroma in variable proportions. CEUS and CECT showed enhancement of the lesions, but the enhancement was less than the adjacent renal parenchyma, leading to the diagnosis of hypovascular renal tumours. All patients were alive and well at the follow-up time of 17-73 months (mean 39.5 months) with CEUS and/or CECT at 3 months, 6 months, and 1 year and then annually thereafter following surgery. No metastases were detected.

CONCLUSIONS

The CEUS and CECT findings of MTSCC were generally hypovascular and needed to be distinguished from other hypovascular renal tumours.

Address: Department of Urology, The Affiliated Nanjing Drum Tower Hospital, Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China.

Link outs

Free resources

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.